| Literature DB >> 24855528 |
Wooseok Im1, Soon-Tae Lee2, Kon Chu2, Manho Kim2, Jae-Kyu Roh2.
Abstract
Huntington's disease (HD) is a progressive and devastating neurodegenerative disorder that results in movement abnormalities, cognitive impairments, dementia, and affective disturbances. As no proven medical therapy for this genetic disease is currently available, symptoms mitigation is the primary treatment for HD. Stem cells can play an important role in cell therapy therapeutic strategies to replace dysfunctional or dying cells in HD. Here, we present a brief overview of the current state of stem cells therapy and of the results obtained in animal models of HD, and discuss neuro-protective approaches that utilize stem cells-derived paracrine factors.Entities:
Keywords: Animal model; Huntington’s disease; Stem cells
Year: 2009 PMID: 24855528 PMCID: PMC4021764 DOI: 10.15283/ijsc.2009.2.2.102
Source DB: PubMed Journal: Int J Stem Cells ISSN: 2005-3606 Impact factor: 2.500